389 related articles for article (PubMed ID: 36831377)
1. The Emerging Role of m6A Modification in Endocrine Cancer.
Ji X; Wang Z; Sun W; Zhang H
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831377
[TBL] [Abstract][Full Text] [Related]
2. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
Liu Q
Front Genet; 2021; 12():825109. PubMed ID: 35087575
[TBL] [Abstract][Full Text] [Related]
3. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate.
Xu Y; Liu J; Chen WJ; Ye QQ; Chen WT; Li CL; Wu HT
Front Cell Dev Biol; 2020; 8():561703. PubMed ID: 33072746
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine (m6A) modification in gynecological malignancies.
Zhang C; Liu N
J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
[TBL] [Abstract][Full Text] [Related]
5. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
Liu WW; Wang H; Zhu XY
Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
[TBL] [Abstract][Full Text] [Related]
6. The role of m6A modification in pediatric cancer.
Chen Y; Miao L; Lin H; Zhuo Z; He J
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188691. PubMed ID: 35122883
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
Front Oncol; 2022; 12():927640. PubMed ID: 35936737
[TBL] [Abstract][Full Text] [Related]
8. N6-Methyladenosine Modifications in Pulmonary Hypertension.
Xia Y; Zhang Y; Huang J; Chen B; Jiang Y; Sun Z; Liu Y
Pharmacology; 2023; 108(6):497-503. PubMed ID: 37742623
[TBL] [Abstract][Full Text] [Related]
9. The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.
Wen T; Li T; Xu Y; Zhang Y; Pan H; Wang Y
Cell Commun Signal; 2023 Dec; 21(1):355. PubMed ID: 38102645
[TBL] [Abstract][Full Text] [Related]
10. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
Chen M; Wong CM
Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of RNA modification N6-methyladenosine in human cancer.
Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
[TBL] [Abstract][Full Text] [Related]
12. m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis.
Jiang X; Jin Z; Yang Y; Zheng X; Chen S; Wang S; Zhang X; Qu N
Front Oncol; 2023; 13():1162300. PubMed ID: 37152066
[TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
14. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
15. The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development.
Liu S; Chen S; Tang C; Zhao Y; Cui W; Jia L; Wang L
Front Oncol; 2022; 12():970833. PubMed ID: 36226062
[TBL] [Abstract][Full Text] [Related]
16. The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.
Cai T; Atteh LL; Zhang X; Huang C; Bai M; Ma H; Zhang C; Fu W; Gao L; Lin Y; Meng W
Front Surg; 2022; 9():819335. PubMed ID: 35155557
[TBL] [Abstract][Full Text] [Related]
17. N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate.
Ji P; Wang X; Xie N; Li Y
Stem Cells Int; 2018; 2018():3256524. PubMed ID: 30405719
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenine RNA modification and cancer.
Yang J; Chen J; Fei X; Wang X; Wang K
Oncol Lett; 2020 Aug; 20(2):1504-1512. PubMed ID: 32724392
[TBL] [Abstract][Full Text] [Related]
19. The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer.
Qiao H; Liu L; Chen J; Shang B; Wang L
Med Oncol; 2022 Sep; 39(12):235. PubMed ID: 36175777
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and clinical landscape of N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers.
Zhu DH; Su KK; Ou-Yang XX; Zhang YH; Yu XP; Li ZH; Ahmadi-Nishaboori SS; Li LJ
Mol Cell Biochem; 2024 Jun; ():. PubMed ID: 38856795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
